Neuren Pharmaceuticals (ASX:NEU) Surges 6% on US$700m DAYBUE Target: Time to Buy?
DAYBUE royalties could climb fast if US targets land Neuren Pharmaceuticals (ASX: NEU) jumped 6% on Wednesday after its US…
Terra Metals (ASX:TM1) This Is How Exploration Stories Get Bigger
Why This Was More Than Just Another Assay Result Terra Metals (ASX:TM1) has delivered an exceptional outcome for investors, with…
3D Energi (ASX:TDO) When Good Drilling News Is Not Good Enough
Why Confirmation Was Not Enough for the Market 3D Energi (ASX:TDO) announced today that drilling at the Charlemont prospect confirmed…
Australia’s Data Centre Boom Is Pushing Your Energy Bills Higher
AI, Data Centres and the Rising Cost of Power in Australia Over the past four years, the global data boom…
Here Are 4 Gen Z trends Reshaping Society: And ASX Stocks Set to Win From Them, And Those Set to Lose
We often hear about Gen Z trends Reshaping Society. And this is not just speculation -there’s growing evidence Gen Z…
Suncorp (ASX:SUN): 18 months removed from retail banking, is it faring better?
In July 2024, Suncorp (ASX:SUN) ceased to be in retail banking following the sale of this division to ANZ. This…
European Lithium (ASX: EUR) Surges 50% as Greenland Pilot Plant Kicks Off: Is It a Buying Opportunity?
European Lithium surges on Greenland Tanbreez milestones European Lithium (ASX: EUR) has climbed roughly 50% from its lows, trading around…
NeuroScientific (ASX:NSB) Reports 75% Response Rate in Crohn’s Trial: Is This Stem Cell Stock a Buy?
NeuroScientific jumps on early Crohn’s stem cell results NeuroScientific Biopharmaceuticals (ASX: NSB) surged 43% on Tuesday after announcing promising early results…
Lynas (ASX:LYC) CEO Amanda Lacaze Steps Down After 12 Years: Buy the Dip or Take Profits?
Lynas CEO Amanda Lacaze steps down after 12 years Lynas Rare Earths (ASX: LYC) shares are in focus after the…
Singular Health (ASX:SHG) Gains FDA Clearance for Cloud Imaging Platform: Is This MedTech a Buy Now?
Singular Health secures FDA clearance for US rollout Singular Health Group (ASX: SHG) grabbed investor attention on Tuesday after the…
Catalina Resources (ASX:CTN) A Drill-Ready Story With Everything Still to Prove
Catalina Resources Chasing Copper at Breakaway Dam Catalina Resources is reshaping its portfolio through a strategic asset swap and targeted…
Electro Optic Systems (ASX:EOS), The MARSS Acquisition That Keeps the Re-Rate Alive
A Deal Built for the New Defence Cycle The US defence budget has now been set at around US$1 trillion,…
Telix Pharmaceuticals (ASX:TLX) Through the Commercialisation Chasm
The Market Lost Patience, the Strategy Did Not Telix Pharmaceuticals (ASX:TLX) is one of the more compelling examples of a…
Liontown Resources (ASX:LTR): From riches to rags, now back to riches again? Here’s what 2026 holds
We’ve all heard the saying ‘rags to riches’ and when Liontown (ASX:LTR) found Kathleen Valley, it was the perfect illustration…
ASX Takeovers in 2026: Here are 5 Struggling Companies We Think Could be Next!
There could be a fair number of ASX Takeovers in 2026 – the year is not less than a fortnight…